dates we develop and our ability to obtain and maintain regulatory approvals for such product candidates for any indication; ● the identification, analysis and use of biomarkers and biomarker data; ●…
NextCure, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NXTC-DEBT
Debt stack $3.9M
90%
Market cache reports total debt of $3.9M.
NextCure, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NextCure, Inc..
NextCure, Inc. Ownership
Holder
Name
Confidence
Evidence
NXTC-OWNER-SQUADRON-CAPITAL-MANAGEMENT-LLC
Squadron Capital Management LLC
90%
13F overlay lists Squadron Capital Management LLC as top holder; 26 tracked holders.
NextCure, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.